2-5 April 2020
Advances in Alzheimer’s and Parkinson’s Therapies, AAT-AD/PD 2020
Location: entirely virtual meeting
e-Poster: “Vafidemstat safety and efficacy in Alzheimer-related agitation & aggression: Phase II REIMAGINE-AD 6-month data”
Oral communication: “Vafidemstat in Alzheimer’s disease: initial 6-month ETHERAL data”